Mintz is a finalist for the “Life Sciences IP Firm of the Year” category in the inaugural Life Sciences Patent Network (LSPN) Awards USA 2025. The awards are organized by Life Sciences Intellectual Property Review and celebrate excellence across the industry—from trailblazing individuals to firms redefining the boundaries of life sciences IP. Judged by an independent panel of experts, the program highlights innovation, dedication, and the unsung heroes driving progress in the life sciences patent community.

The Life Sciences IP Firm of the Year award recognizes law firms that have demonstrated exceptional expertise and impact in the field of life sciences intellectual property over the past 12 months. Judges consider firms' contributions to groundbreaking patent strategies, high-profile cases, client success stories, and overall influence on shaping the life sciences IP landscape. 

Additional information about the LSPN Awards is available here.

Mintz’s Intellectual Property (IP) practice combines technical expertise with a deep understanding of the industry to deliver strategic solutions for life sciences companies. With over 130 IP professionals, including 40+ with PhDs in fields such as biology, biomedical engineering, cellular and molecular medicine, chemistry, and pharmacology, among others, the team offers comprehensive support in patent prosecution, litigation, and advisory services, including in emerging areas like cell-based therapies, life sciences AI, and machine learning. 

About Mintz

Mintz is a litigation powerhouse and business accelerator serving leaders in life sciences, private equity, energy, and technology. The world’s most innovative companies trust Mintz to provide expert advice, protect and monetize their IP, negotiate deals, source financing, and solve complex legal challenges. The firm has over 600 attorneys across offices in Boston, Los Angeles, Miami, New York, Washington, DC, San Francisco, San Diego, and Toronto.